Cardiff Park Advisors’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Cardiff Park Advisors’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,333	Closed	-$21.2K	–	329
2023 Q1	$21.2K	Hold	2,333	–	–	﹤0.01%	295
2022 Q4	$27.4K	Buy	2,333 +196	+9%	+$3.46K	﹤0.01%	287
2022 Q3	$45K	Hold	2,137	–	–	0.01%	283
2022 Q2	$52K	Hold	2,137	–	–	0.01%	280
2022 Q1	$106K	Hold	2,137	–	–	0.01%	254
2021 Q4	$150K	Buy	+2,137	New	+$180K	0.02%	247

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cardiff Park Advisors's VBIV Position: Q2 2023 in Review

Cardiff Park Advisors sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2023, closing a stake of 2,333 shares — an estimated $21.2K sold.

Cardiff Park Advisors first reported a position in VBIV in Q4 2021 and held it in 6 quarters. The position peaked at $150K in Q4 2021. 46 funds tracked by Wall St. Rank hold VBIV as of Q2 2023.

Cardiff Park Advisors reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2023 after selling out during the quarter.
Cardiff Park Advisors sold 2,333 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2023, an estimated $21.2K.
Cardiff Park Advisors first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2021 and held it in 6 quarters.
Cardiff Park Advisors's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $150K in Q4 2021.
46 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2023.

Based on Cardiff Park Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.